NewsBenzingaAllogene Therapeutics 公布其 ALLO-329 I 期 RESOLUTION 试验的初步安全性、有效性和转化数据,将在美国风湿病学会年会上发布 Allogene Therapeutics 公布其 ALLO-329 I 期 RESOLUTION 试验的初步安全性、有效性和转化数据,将在美国风湿病学会年会上发布 Benzinga 2026.11.09 13:05 (GMT+0) Open on Benzinga Other news “AI Stock God” Leopold’s Fund Makes Sweeping Exit From Bitcoin Mining Stocks: IREN Position Slashed 94%, Several Miners Liquidated Wells Fargo: Get Paid to Wait: or Buy at a Discount Is a $1,100 Solana Price Realistic? Bitwise’s Model Has One Big Condition Royal Caribbean Cruises Stock Outlook: Is Wall Street Bullish or Bearish? Anthropic Keeps IPO Price Range Unchanged Daré Bioscience, Inc. (DARE) Q3 2026 Earnings Call Transcript
“AI Stock God” Leopold’s Fund Makes Sweeping Exit From Bitcoin Mining Stocks: IREN Position Slashed 94%, Several Miners Liquidated